Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1.7K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.7K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

1.2K
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.2K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

1.0K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NLRP3 inflammasome: A key player in cardiac fibroblast to myofibroblast transition.

Pathology, research and practice·2026
Same author

Heart failure and mitochondrial dynamics: Role of intracellular angiotensin and emerging therapeutics.

Mitochondrion·2026
Same author

Neuroprotective Phytochemicals Targeting Amyloid and Tau Pathologies.

Current topics in medicinal chemistry·2026
Same author

Color-modulated olfactory testing using RAPPIT: An innovative tool for early detection of cognitive decline.

Journal of Alzheimer's disease : JAD·2026
Same author

Regulation of mitochondrial fission by Drp1 in cardiomyopathy: possible mechanisms linking cellular processes to cell death.

Molecular biology reports·2026
Same author

β<sub>1</sub>/β<sub>2</sub> adrenergic dysregulation: a missing link between mitochondrial fission/fusion in the failing heart.

Journal of receptor and signal transduction research·2026

Related Experiment Video

Updated: May 2, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.1K

Heart failure with normal ejection fraction: a growing pandemic.

Satnam Singh1, Michael Frenneaux

  • 1University of Aberdeen, Level 3, Polwarth building, Foresterhill campus, Aberdeen AB25 2ZD, UK. s.singh@abdn.ac.uk

Future Cardiology
|May 31, 2012
PubMed
Summary

Heart failure with normal ejection fraction is a growing condition affecting 30-50% of patients. Effective evidence-based treatments are currently lacking for this increasingly common heart failure type.

More Related Videos

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.2K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.3K

Related Experiment Videos

Last Updated: May 2, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.1K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.2K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.3K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Heart failure presents heterogeneously, with a significant subset exhibiting normal left ventricular ejection fraction.
  • Epidemiological data indicate a rising prevalence of heart failure with normal ejection fraction (HFNEF).
  • HFNEF is projected to become the predominant form of heart failure, yet lacks established evidence-based therapies.

Purpose of the Study:

  • To review the underlying causes of heart failure with normal ejection fraction.
  • To outline current clinical guidelines for managing HFNEF.
  • To discuss available management strategies for patients with HFNEF.

Main Methods:

  • Literature review of epidemiological studies on heart failure prevalence.
  • Analysis of current clinical practice guidelines for heart failure management.
  • Synthesis of information on treatment options for HFNEF.

Main Results:

  • A substantial proportion (30-50%) of heart failure patients have preserved ejection fraction.
  • The incidence of HFNEF is increasing, suggesting it will soon be the most common heart failure phenotype.
  • Current treatment strategies for HFNEF are not evidence-based.

Conclusions:

  • Heart failure with normal ejection fraction represents a significant and growing clinical challenge.
  • There is an urgent need for the development of effective, evidence-based treatments for HFNEF.
  • Understanding the etiology and adhering to current guidelines are crucial for managing this condition.